Effects of prostaglandins on peripheral progesterone and uterine diamine oxidase in the pregnant hamster.
Serum progesterone and uterine levels of diamine oxidase (DAO) activity were determined during pregnancy in hamsters. Progesterone was elevated on Day 1 of pregnancy, had a transient peak on Day 5, remained relatively constant on Days 6-10, and then increased on Days 13 and 14. Uterine DAO activity could not be detected until Day 7 of pregnancy approximately 1 1/2 days after the initiation implantation. DAO activity was associated with placental tissue, and more than 90% of the activity was localized in the maternal placenta. The temporal relationship between changes in serum concentrations of progesterone and uterine levels of DAO activity following PG administration also was studied. Serum progesterone was significantly depressed by 6 hr after treatment with PGs on Day 7 of pregnancy. However, uterine levels of DAO activity at 6 hr in the treated animals were not different from those in control animals. In contrast, both the serum progesterone concentrations and uterine levels of DAO activity were significantly lower at 24 hr after PG treatment. The effects of PG treatment on uterine DAO activity were completely blocked by concomitant administration of progesterone. However, concomitant administration of Provera only blocked the effect of one PG analog that was tested (9-deoxo-9-methylene-16,16-dimethyl-PGE2). The data indicate that changes in uterine DAO activity following treatment with the PGs used here are primarily a consequence of a decrease in peripheral progesterone (i.e. a luteolytic effect of the PG).
D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism*; D000818:Animals; D006224:Cricetinae; D005260:Female; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D008647:Mesocricetus; D010920:Placenta / Q000187:drug effects / Q000201:enzymology; D011247:Pregnancy; D011374:Progesterone / Q000097:blood* / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects / Q000201:enzymology*
D011458:Prostaglandins E; D011460:Prostaglandins F; D011374:Progesterone; D017258:Medroxyprogesterone Acetate; D006631:Amine Oxidase (Copper-Containing); D008525:Medroxyprogesterone